Mezher Hussein Ali,Daniel Christopher Brookings,Julien Alistair Brown,Victoria Elizabeth Jackson,Boris Kroeplien,John Robert Porter
申请号：
US15100690
公开号：
US09932342B2
申请日:
2014.12.08
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A series of substituted imidazo[1,2-a]pyrimidine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders； neurological and neurodegenerative disorders； pain and nociceptive disorders； cardiovascular disorders； metabolic disorders； ocular disorders； and oncological disorders.
